LOXL2 and neoplasm: Peinado et al. demonstrated that LOXL2 and LOXL3 interacted with SNAI1 to induce epithelial to mesenchymal transition, and knockdown of LOXL2 alone decreased tumor growth and reduced invasive and angiogenic markers within the tumors [117].